Early Diagnosis of Oral Cancer by Detecting p16 Methylation

A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Methylation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01695018

Enrollment

180

Registered

2012-09-27

Start date

2009-02-28

Completion date

Unknown

Last updated

2014-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Epithelial Dysplasia, Moderate Epithelial Dysplasia

Keywords

oral epithelial dysplasia, p16 methylation, diagnostic reagents, early diagnosis

Brief summary

The purpose of this study is to verify the function of p16 methylation diagnostic reagents in early diagnosis of oral cancer.

Detailed description

Background:Oral epithelial dysplasia (OED) is one of the common precancerous lesions among Chinese adults. To investigate the clinical predictive value of p16 methylation diagnostic reagents in the early diagnosis of oral cancer, the investigators carried out the prospective multi-center double-blind cohort study. Methods:180 patients with histologically confirmed mild or moderate OED were included in the present study. The investigators using p16 methylation diagnostic reagents to analysis of the p16 methylation status in these patients. Building two follow-up queue by p16-methylated and p16-unmethylated. The Statistical analysis used SAS6.12 software. All P-values were two-sided. P\<0.05 was considered to test for statistical significance difference.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

25 Years to 78 Years

Healthy volunteers

Inclusion criteria

* Histopathological diagnosis of oral lesions meet the epithelial diagnostic criteria for mild to moderate grade OED * No local area stimulate by residual root and crown, sharp cusp, poor restoration and biting cheek or lips * Without the OCE treatment history by laser , radiation or chemical * Be able to Sign the informed consent

Exclusion criteria

* Histopathological diagnosis of oral lesions do not meet the epithelium of mild to moderate dysplasia diagnostic criteria; histological diagnosis of severe grade OED or malignant disease * Pregnancy or breast-feeding women * Serious heart, lung, liver , kidney and other systemic diseases * local area stimulate by residual root and crown, sharp cusp, poor restoration and biting cheek or lips * OED treatment history by LASER, radiotherapy, or chemotherapy * Tumor and psychiatric patients * Patients are unable to cooperate

Design outcomes

Primary

Measure	Time frame	Description
Cancer rate in patients with oral epithelial dysplasia containing or NOT containing p16 methylation	frome 3 months to 63 months	152 participants were p16 methylated informative. 29 participants were NOT informative because enough DNA was not extracted from their paraffin slides. Among these informative cases, oral specimens from 48 patients were p16 methylation positive and 104 patients were p16 methylation negative. The cancer rate in the p16 methylation positive patients during the followup period will be compared with that in the p16 methylation negative patients statistically.

Outcome results